CSF2 and neoplasm: Previous studies on cancer immunotherapy using cytokines showed that the systemic administration of GM-CSF had some clinical benefits in treating PC, pulmonary metastases, and melanoma, perhaps via stimulation of the immune system anti-tumor responses (105).